Maria Cherska: Insights from EAS 2025 on Detection and Long-Term Management of FH
Maria Cherska, The head of cardiology department at The State Institution «V.P. Komisarenko Institute of Endocrinology and Metabolism», shared a post on LinkedIn:
“Familial Hypercholesterolemia (FH): Rethinking Detection and Long-Term Management — Insights from EAS 2025
Familial hypercholesterolemia remains substantially underdiagnosed worldwide, despite being a major driver of premature atherosclerotic cardiovascular disease. The gap between guideline recommendations and real-world implementation is still significant.
In this expert interview from EAS 2025, Prof. Gerald Watts discusses the evolving clinical strategy for FH management — from early identification and cascade screening to long-term LDL-C control and residual risk reduction.
Key clinical takeaways:
- Systematic early detection is critical
- Cascade screening should be integrated into routine practice
- Aggressive and sustained LDL-C lowering is essential
- Residual cardiovascular risk persists even after LDL-C reduction
FH is not a rare condition — it is a common, lifelong, high-risk state that requires proactive and structured management.
Read the Full Interview.
For cardiologists, lipidologists, endocrinologists, internists, and preventive cardiology specialists focused on high-risk patient care and long-term ASCVD prevention.
How do you currently implement cascade screening and long-term LDL-C control in FH patients?”
Stay updated with Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation